Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangmin Xu

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|July 12, 2021
Dietary Betaine Mitigates Hepatic Steatosis and Inflammation Induced by a High-Fat-Diet by Modulating the Sirt1/Srebp-1/Pparɑ Pathway in Juvenile Black Seabream (<i>Acanthopagrus schlegelii</i>)Min Jin, Yuedong Shen, Tingting Pan, et al.
Journal of Neurointerventional Surgery|June 4, 2014
Preliminary in vivo evaluation of a novel intrasaccular cerebral aneurysm occlusion deviceRoham Moftakhar, Fangmin Xu, Beverly Aagaard-Kienitz, et al.
Health Data Science|June 10, 2026
Electronic Health Record-Based Machine Learning Model for Predicting Disease Activity in Patients with Rheumatoid ArthritisXiaoying Zhang, Chun Li, Zelin Yun, et al.
Food Chemistry|March 24, 2021
Untargeted lipidomics reveals metabolic responses to different dietary n-3 PUFA in juvenile swimming crab (Portunus trituberculatus)Ye Yuan, Fangmin Xu, Min Jin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Identification of Three Distinct Subgroups in Antiphospholipid Syndrome: Implication for Sex Differences and Prognostic Outcomes from a Multicenter StudyChen Chen, Ao Zhang, Jianhui Cheng, et al.
Oncoimmunology|January 9, 2018
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacyCatherine A Sabatos-Peyton, James Nevin, Ansgar Brock, et al.
Immunotherapy Advances|October 5, 2022
Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptorStephanie Schwartz, Nidhi Patel, Tyler Longmire, et al.
Nature Chemical Biology|December 11, 2019
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complexDirksen E Bussiere, Lili Xie, Honnappa Srinivas, et al.
Nature Chemical Biology|January 17, 2020
Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complexDirksen E Bussiere, Lili Xie, Honnappa Srinivas, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 12, 2021
Dietary Betaine Mitigates Hepatic Steatosis and Inflammation Induced by a High-Fat-Diet by Modulating the Sirt1/Srebp-1/Pparɑ Pathway in Juvenile Black Seabream (<i>Acanthopagrus schlegelii</i>)Min Jin, Yuedong Shen, Tingting Pan, et al.
Journal of Neurointerventional Surgery|June 4, 2014
Preliminary in vivo evaluation of a novel intrasaccular cerebral aneurysm occlusion deviceRoham Moftakhar, Fangmin Xu, Beverly Aagaard-Kienitz, et al.
Health Data Science|June 10, 2026
Electronic Health Record-Based Machine Learning Model for Predicting Disease Activity in Patients with Rheumatoid ArthritisXiaoying Zhang, Chun Li, Zelin Yun, et al.
Food Chemistry|March 24, 2021
Untargeted lipidomics reveals metabolic responses to different dietary n-3 PUFA in juvenile swimming crab (Portunus trituberculatus)Ye Yuan, Fangmin Xu, Min Jin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 18, 2025
Identification of Three Distinct Subgroups in Antiphospholipid Syndrome: Implication for Sex Differences and Prognostic Outcomes from a Multicenter StudyChen Chen, Ao Zhang, Jianhui Cheng, et al.
Oncoimmunology|January 9, 2018
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacyCatherine A Sabatos-Peyton, James Nevin, Ansgar Brock, et al.
Immunotherapy Advances|October 5, 2022
Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptorStephanie Schwartz, Nidhi Patel, Tyler Longmire, et al.
Nature Chemical Biology|December 11, 2019
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complexDirksen E Bussiere, Lili Xie, Honnappa Srinivas, et al.
Nature Chemical Biology|January 17, 2020
Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complexDirksen E Bussiere, Lili Xie, Honnappa Srinivas, et al.
Molecular Cancer Therapeutics|August 28, 2020
Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell MalignanciesHaihui Lu, Ryan D Molony, Dongshu Chen, et al.
Pageof 5